Skip to content
Lower risk Drug recall · FDA · Published April 26, 2023

Apotex Calcitonin Nasal Spray Recall: Glass Splinter Risk

Apotex recalls nasal spray with glass splinter risk. Foreign particles in pump may cause malfunction. Stop using immediately if affected.

🇺🇸 FDA recall #D-0568-2023DrugApotex ›
Take action

Contact the company

Recalling firmApotex Corp.2400 N Commerce Pkwy Ste 400 · Weston, FL 33326-3253
✎ GovInfoNow plain-language explainer

Apotex is recalling nasal spray that contains glass splinters in the pump mechanism. This could cause the spray to stop working properly, but it does not pose a direct injury risk to users. Read more at govinfonow.com/recall/33711-apotex-calcitonin-nasal-spray-recall-glass-splinter-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/33711-apotex-calcitonin-nasal-spray-recall-glass-splinter-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0568-2023

Cite this page

“Apotex Calcitonin Nasal Spray Recall: Glass Splinter Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33711-apotex-calcitonin-nasal-spray-recall-glass-splinter-risk. Based on FDA recall #D-0568-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0568-2023%22&limit=1).

The FDA announced on April 26, 2023, that Apotex Corp. is recalling Calcitonin Salmon Nasal Spray due to the presence of glass splinter particles in the pump ball seat. This defect rendered the pump inoperable for some units.

How to tell if you have it

  • Brand: Apotex
  • Product: Calcitonin Salmon (synthetic origin) Nasal Spray, 2200 USP Calcitonin Salmon Units/mL, 200 USP Calcitonin Salmon Units/spray, 3.7 mL bottle
  • NDC: 60505-0823-6
  • Lot #: TH5645
  • Expiration: 01/2025

The hazard

The recall addresses the presence of foreign substance, specifically glass splinter particles entrapped inside the pump ball seat. This defect rendered the pump inoperable.

Context

GovInfoNow's records show Apotex Corp. has 24 other recalls on record since June 14, 2007. Recent Apotex recalls include a Paroxetine 37.5mg recall on September 23, 2026, due to dissolution failure and a Paxil CR 37.5mg Tablets recall on August 13, 2026, for failed stability testing. Other recent recalls of similar products include Medinatura ReBoost Nasal Spray (December 12, 2025) and Walgreens Saline Nasal Spray with Xylitol (November 12, 2025), both citing microbial contamination risk.

How to tell if you have this one

Check for the product name 'Calcitonin Salmon (synthetic origin) Nasal Spray', 2200 USP units per mL, and lot number TH5645. The product was manufactured by Apotex Corp. in Toronto, Canada.

  • Brand
    Apotex
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the product name, strength, and lot number to confirm if it's recalled.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide throughout the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 21 days after the firm started it.

1. Firm started the recall: Apr 26, 202312. FDA classified it Class II: May 9, 202323. Published in FDA’s Enforcement Report: May 17, 202332023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Apotex recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0568-2023 (April 26, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0568-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA